PHILIP BATH philip.bath@nottingham.ac.uk
Stroke Association Professor of Stroke Medicine
Baseline characteristics of the 3,096 patients recruited into the 'Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke' (TARDIS) trial
Bath, Philip M.W.; Appleton, Jason P.; Beridze, M.; Christensen, Hanne; Dineen, Robert A.; Duley, Lelia; England, Timothy J.; Heptinstall, Stan; James, Marilyn; Krishnan, Kailash; Markus, H.S.; Pocock, Stuart J.; Ranta, A.; Robinson, Thompson G.; Flaherty, Katie; Scutt, Polly; Venables, G.; Woodhouse, Lisa J.; Sprigg, Nikola
Authors
Jason P. Appleton
M. Beridze
Hanne Christensen
Robert A. Dineen
Lelia Duley
Timothy J. England
Stan Heptinstall
MARILYN JAMES MARILYN.JAMES@NOTTINGHAM.AC.UK
Professor of Health Economics
Kailash Krishnan
H.S. Markus
Stuart J. Pocock
A. Ranta
Thompson G. Robinson
Katie Flaherty
Polly Scutt
G. Venables
Lisa J. Woodhouse
NIKOLA SPRIGG nikola.sprigg@nottingham.ac.uk
Professor of Stroke Medicine
Abstract
Background: The risk of recurrence following ischaemic stroke (IS) or transient ischaemic attack (TIA) is highest immediately after the event. Antiplatelet agents are effective in reducing the risk of recurrence and two agents are superior to one in the early phase after ictus.
Design: The Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial was an international multicentre prospective randomised open-label blinded-endpoint trial that assessed the safety and efficacy of short-term intensive antiplatelet therapy with three agents (combined aspirin, clopidogrel and dipyridamole) as compared with guideline treatment in acute IS or TIA. The primary outcome was stroke recurrence and its severity, measured using the modified Rankin Scale at 90 days. Secondary outcomes included recurrent vascular events, functional measures (cognition, disability, mood, quality of life) and safety (bleeding, death, serious adverse events). Data are number (%) or mean (standard deviation, SD).
Results: Recruitment ran from April 2009 to March 2016. 3,096 patients were recruited from 106 sites in 4 countries (Denmark 1.6%, Georgia 2.7%, New Zealand 0.2%, UK 95.4%). Randomisation characteristics included: age 69.0 (10.1) years; male 1945 (62.8%); time onset to randomisation 29.4 (11.9) hours; stroke severity (National Institutes for Health Stroke Scale) 2.8 (3.6); blood pressure 143.5 (18.2)/79.5 (11.4) mmHg; IS 2143 (69.2%), TIA 953 (30.8%).
Conclusion: TARDIS was a large trial of intensive/triple antiplatelet therapy in acute IS and TIA, and included participants from four predominantly Caucasian countries who were representative of patients in many western stroke services.
Citation
Bath, P. M., Appleton, J. P., Beridze, M., Christensen, H., Dineen, R. A., Duley, L., …Sprigg, N. (2017). Baseline characteristics of the 3,096 patients recruited into the 'Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke' (TARDIS) trial. International Journal of Stroke, 12(5), 524-538. https://doi.org/10.1177/1747493016677988
Journal Article Type | Article |
---|---|
Acceptance Date | Sep 21, 2016 |
Online Publication Date | Nov 4, 2016 |
Publication Date | Jul 1, 2017 |
Deposit Date | Nov 21, 2016 |
Publicly Available Date | Nov 21, 2016 |
Journal | International Journal of Stroke |
Print ISSN | 1747-4930 |
Electronic ISSN | 1747-4949 |
Publisher | SAGE Publications |
Peer Reviewed | Peer Reviewed |
Volume | 12 |
Issue | 5 |
Pages | 524-538 |
DOI | https://doi.org/10.1177/1747493016677988 |
Keywords | Acute ischaemic stroke, Acute transient ischaemic attack (TIA), Aspirin, Bleeding, Clopidogrel, Dipyridamole, Randomised controlled trial |
Public URL | https://nottingham-repository.worktribe.com/output/869292 |
Publisher URL | http://journals.sagepub.com/doi/10.1177/1747493016677988 |
Contract Date | Nov 21, 2016 |
Files
1747493016677988.pdf
(5.1 Mb)
PDF
Copyright Statement
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by/4.0
You might also like
Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke
(2016)
Journal Article
Stroke outcome in clinical trial patients deriving from different countries
(2008)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search